Sign Up to like & get
recommendations!
1
Published in 2017 at "Nature Biotechnology"
DOI: 10.1038/nbt.3917
Abstract: The anticipated decline in the biotech industry's ability to raise capital from public investors and an accompanying slump in biotech markets materialized in 2016, but all is not gloom and doom.
read more here.
Keywords:
public biotech;
2016 numbers;
biotech 2016;
biotech ... See more keywords